What is Global Blood Glucose Test Strips Market?
The Global Blood Glucose Test Strips Market is a significant segment of the healthcare industry that focuses on the production and distribution of blood glucose test strips. These strips are essential tools used in the monitoring and management of diabetes, a chronic disease that affects millions of people worldwide. The test strips work by analyzing a small sample of blood, usually drawn from a finger, to measure the amount of glucose, or sugar, in the blood at any given time. This information is crucial for individuals with diabetes who need to keep their blood sugar levels within a specific range to manage their condition effectively. The global market for these test strips is vast and diverse, with numerous manufacturers and distributors operating in various regions around the world. In 2022, the market was valued at US$ 10140 million, and it is projected to grow to US$ 13030 million by 2029. This growth is driven by the increasing prevalence of diabetes and the ongoing need for effective blood glucose monitoring tools.
Glucose Oxidase, Glucose Dehydrogenase in the Global Blood Glucose Test Strips Market:
The Global Blood Glucose Test Strips Market is divided into two main categories based on the type of enzyme used in the test strips: glucose oxidase and glucose dehydrogenase. Glucose oxidase is an enzyme that reacts with glucose in the blood to produce hydrogen peroxide. This reaction is then measured by the test strip to determine the blood glucose level. On the other hand, glucose dehydrogenase reacts with glucose to produce a different compound, which is also measured by the test strip. Both types of test strips are widely used in the market, with different manufacturers preferring one type over the other based on various factors such as cost, accuracy, and ease of use. In the Asia-Pacific region, the market for these test strips is dominated by a few key players, including ARKRAY, Sinocare, and I-SENS, which collectively account for about 34% of the market share.
Hospital, Clinic, Household in the Global Blood Glucose Test Strips Market:
The Global Blood Glucose Test Strips Market serves a wide range of end-users, including hospitals, clinics, and households. In hospitals and clinics, these test strips are used by healthcare professionals to monitor the blood glucose levels of patients with diabetes. This monitoring is crucial in managing the disease and preventing complications such as hyperglycemia and hypoglycemia. In households, individuals with diabetes use these test strips as part of their daily self-monitoring routine. Regular self-monitoring of blood glucose levels helps individuals manage their diabetes more effectively by enabling them to make informed decisions about their diet, physical activity, and medication. The use of these test strips in households is particularly prevalent in developed countries where home-based diabetes management is more common.
Global Blood Glucose Test Strips Market Outlook:
To rephrase the market outlook, the Global Blood Glucose Test Strips Market, which was valued at US$ 10140 million in 2022, is expected to grow to US$ 13030 million by 2029, with a compound annual growth rate (CAGR) of 3.6% during the forecast period from 2023 to 2029. This growth is driven by the increasing prevalence of diabetes and the ongoing need for effective blood glucose monitoring tools. In the Asia-Pacific region, the market is dominated by a few key players, including ARKRAY, Sinocare, and I-SENS, which collectively account for about 34% of the market share.
| Report Metric | Details |
| Report Name | Blood Glucose Test Strips Market |
| Accounted market size in 2022 | US$ 10140 in million |
| Forecasted market size in 2029 | US$ 13030 million |
| CAGR | 3.6% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | I-SENS, Osang Healthcare, SD Biosensor, PHC Holdings, ARKRAY, Terumo, Omron, Sinocare, Yicheng, Yuwell, Acon, Sinomedisite, Vivacheck, Empecs, Andon, Mycura, Bioland, Kanghe, Royalyze, Urit, Hengsheng, Wondfo, Assure, Jianqiao, Weitai, Lepu, Sejoy, Ruifu, Baoruiyuan, Maike, Aurum, General life, Apex, Bioptik, EPS, Visgeneer, HMD, Health&life, Taidoc, Bionime, OK Biotech |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
